DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Husain M, Birkenfeld AL, Donsmark M, PIONEER 6 Investigators et al.
Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes.
N Engl J Med 2019;
DOI: 10.1056.
Access:
We do not assume any responsibility for the contents of the web pages of other providers.